Tesamorelin + Ipamorelin 10mg Blend
Components: Tesamorelin + Ipamorelin
A GH secretagogue blend combining Tesamorelin (5mg) and Ipamorelin (5mg) in a 10mg vial. Tesamorelin is FDA-approved for visceral fat reduction. Together they target body composition and GH optimization.
Blend Composition
This is a single pre-mixed vial — one reconstitution for all components.
Synergy Explanation
Tesamorelin is a stabilized GHRH analogue with FDA approval for HIV-associated lipodystrophy — clinically demonstrated to reduce visceral adipose tissue. Ipamorelin adds complementary GH pulse stimulation through the ghrelin receptor. The combination amplifies both GHRH and GHRP mechanisms for superior GH release and body composition effects.
Reconstitution Guide
-
Allow the vial to reach room temperature for 5 minutes before handling.
-
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
-
Sterilize the vial stopper with an alcohol swab and allow to dry.
-
Inject the BAC water slowly down the inside wall of the vial.
-
Gently swirl or roll until fully dissolved. Do not shake.
-
Label with reconstitution date and refrigerate at 2u20138 u00b0C (35.6u201346.4 u00b0F). Use within 24u201348 hours.
Always use bacteriostatic water — not sterile water — to extend shelf life of your reconstituted blend.
Dosage Protocols
| Protocol | Dose | Frequency | Duration | Route | Notes |
|---|---|---|---|---|---|
| 16-Week Titration Protocol | 250 mcg Tesamorelin / 125 mcg Ipamorelin increasing to 2000 mcg / 1000 mcg once daily | Once daily | 16 weeks | SubQ | Begin at 250 mcg Tesamorelin / 125 mcg Ipamorelin daily. Gradually increase over 16 weeks to a maximum of 2000 mcg Tesamorelin / 1000 mcg Ipamorelin daily as tolerated. Administer in the evening. |
Storage Instructions
Lyophilized (Dry)
Refrigerate at 2–8 °C (35.6–46.4 °F). Do not freeze lyophilized Tesamorelin-containing products.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F). Use within 24–48 hours of reconstitution.
Tesamorelin has unique storage requirements — do not freeze lyophilized vials. Reconstituted solution must be used within 24–48 hours for optimal stability. Do not store reconstituted solution for extended periods.
Supplies Needed
-
Bacteriostatic water (BAC water) 10 mL vial
-
Insulin syringes (U-100) 0.5 mL, 29u201331 gauge
-
Alcohol swabs For stopper and injection site sterilization
Potential Side Effects
Possible water retention, joint stiffness, and peripheral edema from elevated GH. Injection site reactions. Tesamorelin should not be used in individuals with active malignancy or hypothalamic/pituitary dysfunction.
Questions about Tesamorelin + Ipamorelin 10mg Blend
Tesamorelin is the only GHRH analogue with FDA approval u2014 specifically for visceral fat reduction in HIV-associated lipodystrophy. It has robust clinical trial data showing meaningful reductions in visceral adipose tissue, distinguishing it from research-only GHRH analogues.
Tesamorelin has reduced solution stability compared to most peptides. The manufacturer's guidelines for the pharmaceutical formulation specify a short window after reconstitution. Reconstitute only what you need for the next 1u20132 days.
Research Use Disclaimer
This content is for educational purposes only and does not constitute medical advice. For research use only.